PROG
Price:
$0.8845
Market Cap:
$994.99K
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company develops targeted oral delivery of biotherapeutics, including PGN-600, an orally delivered liquid formulation of tofacitinib for the treatment of ulcerative colitis; and PGN-001, an orally delivered variant of adalimumab for the treatment of ulcerative colitis. It also develops systemic oral delivery of biotherapeutics, which include PGN-OB, a combination product of a variant of adalimumab and the Oral Biotherapeutics Delivery System (OBDM) for the treatment of inflammatory conditions; and PGN-OB2, a combination product of a GLP-1 receptor agonist and th...[Read more]
Industry
Biotechnology
IPO Date
2020-06-19
Stock Exchange
NASDAQ
Ticker
PROG
According to Biora Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 12.18%. This represents a change of 65.77% compared to the average of 7.35% of the last 4 quarters.
The mean historical ROE of Biora Therapeutics, Inc. over the last ten years is 179.24%. The current 12.18% ROE has changed -93.20% with respect to the historical average. Over the past ten years (40 quarters), PROG's ROE was at its highest in in the June 2020 quarter at 307.59%. The ROE was at its lowest in in the June 2024 quarter at -7.24%.
Average
179.24%
Median
178.22%
Minimum
37.30%
Maximum
349.24%
Discovering the peaks and valleys of Biora Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 228.05%
Maximum Annual ROE = 349.24%
Minimum Annual Increase = -82.24%
Minimum Annual ROE = 37.30%
| Year | ROE | Change |
|---|---|---|
| 2023 | 122.38% | 228.05% |
| 2022 | 37.30% | -82.24% |
| 2021 | 210.08% | 16.75% |
| 2020 | 179.94% | 1.95% |
| 2019 | 176.50% | -49.46% |
The current ROE of Biora Therapeutics, Inc. (PROG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
123.25%
5-year avg
145.24%
10-year avg
179.24%
Biora Therapeutics, Inc.’s ROE is greater than Turnstone Biologics Corp. (-171.86%), greater than Tvardi Therapeutics, Inc. (-115.90%), greater than Omega Therapeutics, Inc. (-173.25%), greater than COSCIENS Biopharma Inc. (-149.40%), less than Channel Therapeutics Corporation (243.75%), less than Apexigen, Inc. (48.27%), less than Kineta, Inc. (71.50%), greater than Neoleukin Therapeutics, Inc. (-39.98%), greater than ESSA Pharma Inc. (-21.70%), greater than CervoMed Inc. (-59.15%),
| Company | ROE | Market cap |
|---|---|---|
| -171.86% | $8.21M | |
| -115.90% | $41.37M | |
| -173.25% | $7.90M | |
| -149.40% | $6.68M | |
| 243.75% | $8.90M | |
| 48.27% | $9.57M | |
| 71.50% | $7.05M | |
| -39.98% | $8.20M | |
| -21.70% | $9.52M | |
| -59.15% | $78.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biora Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biora Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Biora Therapeutics, Inc.'s ROE?
How is the ROE calculated for Biora Therapeutics, Inc. (PROG)?
What is the highest ROE for Biora Therapeutics, Inc. (PROG)?
What is the 3-year average ROE for Biora Therapeutics, Inc. (PROG)?
What is the 5-year average ROE for Biora Therapeutics, Inc. (PROG)?
How does the current ROE for Biora Therapeutics, Inc. (PROG) compare to its historical average?